Human Immunodeficiency Virus Glycoprotein gp120 as the Primary Target for the Antiviral Action of AR177 (Zintevir)

José A. Esté; Cecilia Cabrera; Dominique Schols; Peter Cherepanov; Arantxa Gutiérrez; Myriam Witvrouw; Christophe Pannecouque; Zeger Debyser; Robert F. Rando; Bonaventura Clotet; Jan Desmyter; De Clercq Erik

doi:10.1124/mol.53.2.340

Back

Human Immunodeficiency Virus Glycoprotein gp120 as the Primary Target for the Antiviral Action of AR177 (Zintevir)

Article 1998 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article1997

Human immunodeficiency virus gp120 as the primary target of action of AR177 (Zintevir)

José A. Esté, Dominique Schols, Myriam Witvrouw, Peter Cherepanov, Christophe Pannecouque, Robert F. Rando, Zeger Debyser, Jan Desmyter, De Clercq Erik

Article1999

Human Immunodeficiency Virus Gene Regulation as a Target for Antiviral Chemotherapy

Dirk Daelemans, Anne‐Mieke Vandamme, De Clercq Erik

Article1995

Antiviral therapy for human immunodeficiency virus infections.

De Clercq Erik

Article1995

Antiviral therapy for human immunodeficiency virus infections

De Clercq Erik

Article1997

Development of Resistance of Human Immunodeficiency Virus Type 1 to Dextran Sulfate Associated with the Emergence of Specific Mutations in the Envelope gp120 Glycoprotein

José A. Esté, Dominique Schols, K De Vreese, Kristel Van Laethem, Anne‐Mieke Vandamme, Jan Desmyter, De Clercq Erik